Press release
Why The Right Enterprise Oncology/Cancer Drugs May Be The Best Investment You Make This Year
The global oncology drugs market is expected to reach at $111.9 billion by 2020. Patent expiration of key cancer drugs such as Herceptin, Erbitux, Rituxan and Avastin, is expected to boost the growth of cancer biosimilars market by 2020. Going further, the biological therapies are expected to dominate the market by 2020, due to their high efficacy, target specific action and less toxicity. Blood cancer drugs market was the largest revenue generating segment in 2013 owing to the high cost of drugs (immunotherapies) used for the treatment of blood cancer.Biological drugs based on monoclonal antibodies (mAbs) have emerged as a preferred option for treating various cancer types, especially for blood cancer (leukemia). Rising incidence of various cancer conditions, growing popularity of advance therapies (biological and targeted drug therapies), patents expiration of leading drugs along with commercialization of biosimilars are the few factors driving the growth of global oncology drugs market. However, high cost involved in new drug development coupled with threat of failure and adverse effects associated with cancer drugs therapies would restrain the growth of the market. Commercialization of advanced therapeutics such as targeted and immunotherapies would reduce the negative influence of restraints and fuel the market growth.
Save Upto 15% on this Report @ http://bit.ly/2zM48xE
Geographically, North America, dominates the market followed by Europe. North America accounted for about ~38% share in the overall oncology drugs market in 2013 owing to the heavy investments by multinational companies in research and development of cancer drugs, particularly immune therapeutics, favorable reimbursement policies, and high adoption rate of immunotherapies. On the other hand, Asia-Pacific market would grow at the promising CAGR of 8.7% during the forecast period. Such high growth rate is majorly due to increasing awareness towards advanced therapies namely immunotherapies and increase in per capita healthcare spending.
Key companies profiled in the report are Roche diagnostics, Novartis AG, Celgene Corporation, AstraZeneca, Johnson & Johnson, Merck & Co., Eli Lilly & Co. and GlaxoSmithKline. Companies operating in the cancer drugs market focus on several strategies such as collaboration, approval and acquisition.
Get the sample PDF Brochure of market study @ http://bit.ly/2ioXTFV
KEY BENEFITS
• The report provides the quantitative analysis of the current market and estimations through 2013-2020 that assists in identifying the prevailing market opportunities to capitalize on
• The report helps in understanding the strategies adopted by various companies for gaining market share in the cancer drugs market
• The report provides comprehensive analysis of factors that drive and restrict the growth of the cancer drugs market
• Market conditions of cancer drugs market across all geographic regions are comprehensively analyzed
• Competitive intelligence (of leading manufacturers) helps in understanding the competitive scenario across the geographies
• SWOT analysis of the key market players is provided to illustrate the business strategies adopted by the companies
MARKET SEGMENTATION
The cancer drugs market is segmented by the therapeutic modalities, cancer types and geography.
MARKET BY THERAPEUTIC MODALITIES
• Chemotherapy
• Targeted Therapy
• Immunotherapy (Biologic Therapy)
• Hormonal Therapy
• Others
MARKET BY CANCER TYPES
• Blood Cancer
• Breast Cancer
• Gastrointestinal Cancer
• Prostate Cancer
• Respiratory/Lung Cancer
• Skin Cancer
• Other Cancers
MARKET BY GEOGRAPHY
• North America
o United States
o Canada
o Mexico
• Europe
o Germany
o France
o United Kingdom
o Others
• Asia-Pacific
o India
o China
o Japan
o Australia
o Others
• LAMEA
o GCC (Gulf Corporation Council)
o Others
Enquire About Report@ http://bit.ly/2myNqwi
Contact Us
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
Toll Free: +1 (800) 910-6452
Int'l: +1-971-202-1575
help@researchbeam.com
About Us
It is crucial for market players to take leaps strategically and update themselves with recent trends, opportunities, and emerging investment pockets. We, at “Research Beam”, adhere to these factors and offer a wide range of reports that are detailed and enable our clients to achieve their goals with long term planning coupled with competitive advantage.
Our database includes a broad array of various market reports from numerous publishers across the globe. These reports of several market categories and sub-categories help our clients to find the exact report they are looking for. We are instrumental to provide quantitative and qualitative insights in their area of interest and bring reports from various publishers under one umbrella to save their time and money. Our clients across the world are gaining profits from the information given in the reports sourced by us.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Why The Right Enterprise Oncology/Cancer Drugs May Be The Best Investment You Make This Year here
News-ID: 821558 • Views: …
More Releases from Research Beam

Proton Therapy Market: Global Analysis & Forecast by Koninklijke Philips N.V., A …
Market study on Global Proton Therapy Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023 Research Report presents a professional and complete analysis of Global Proton Therapy Market on the current market situation.
This report focuses on the Proton Therapy in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Request…

Artificial Lift System Market by Top Key Participant The major companies profile …
The market research report ‘Global Artificial Lift System, 2018 Market Research Report’ aims to offer insights into new business opportunities for companies active in Artificial Lift Systemas well as for those players that are aiming to get an entry into the industry.
Artificial Lift System Market by Type (Rod lift, ESP, PCP, Plunger, Gas lift, Others), Component (Pump, Motor, Cable System, Drive head, Separator, Pump Jack, Sucker Rod, Gas-lift Valves,…

Artificial Intelligence in Healthcare Market Report Competition by Manufacturers …
Artificial Intelligence in Healthcare Market by Offering (Hardware, Software, and Services), Technology (Deep Learning, Querying Method, Natural Language Processing, and Context Aware Processing), Application (Robot-assisted Surgery, Virtual Nursing Assistant, Administrative Workflow Assistance, Fraud Detection, Dosage Error Reduction, Clinical Trial Participant Identifier, Preliminary Diagnosis, and Others), and End User (Healthcare Provider, Pharmaceutical & Biotechnology Company, Patient, and Payer) - Global Opportunity Analysis and Industry Forecast, 2017-2023
Request Sample copy of this Report…

Artificial Turf Market Key Player Analysis By - Victoria PLC (Avalon Grass), Spo …
Artificial turfs are synthetic surfaces made of fibers including polyethylene, polypropylene, and polyamides. These are used across the globe due to attractive features such as high durability, low maintenance, superior quality, all weather utility, visual appeal, and eco-friendly attribute. Such turfs are in high demand in sports such as football, hockey, baseball, golf, and other activities that require a durable grass surface. Furthermore, these turfs can be 100% recycled due…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…